Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

Abstract Pompe disease is a metabolic myopathy due to acid alpha‐glucosidase deficiency. In addition to glycogen storage, secondary dysregulation of cellular functions, such as autophagy and oxidative stress, contributes to the disease pathophysiology. We have tested whether oxidative stress impacts...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Antonietta Tarallo, Carla Damiano, Sandra Strollo, Nadia Minopoli, Alessia Indrieri, Elena Polishchuk, Francesca Zappa, Edoardo Nusco, Simona Fecarotta, Caterina Porto, Marcella Coletta, Roberta Iacono, Marco Moracci, Roman Polishchuk, Diego Luis Medina, Paola Imbimbo, Daria Maria Monti, Maria Antonietta De Matteis, Giancarlo Parenti
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	alpha‐glucosidase enzyme replacement therapy N‐acetylcysteine oxidative stress Pompe disease Medicine (General) R5-920 Genetics QH426-470
Accès en ligne:	https://doaj.org/article/c9d76b1dfda5478da27f60239b67fa37
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

Documents similaires